The effectiveness of intermediate recombination in evolution strategies is analyzed in light of the typical procedure of initializing trial solutions uniformly about the global optimum of benchmark functions. Analysis indicates that this procedure may predispose results in favor of intermediate recombination.
No takes yet. Share an insight, caveat, or question.
Fogel et al. (1995) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: